http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Boston Scientific To Participate In Wells Fargo 2016 Healthcare Conference
-
Boston Scientific Announces U.S. FDA Approval Of EMBLEM™ MRI S-ICD System
-
Boston Scientific To Participate In Canaccord Genuity Growth Conference And Wedbush PacGrow Healthcare Conference
-
Boston Scientific Announces Results For Second Quarter 2016
-
Boston Scientific (BSX) Acquires RFA Systems Makter Cosman Medical
-
Boston Scientific Announces Acquisition of Cosman Medical
-
Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
-
Boston Scientific To Webcast Conference Call Discussing Second Quarter 2016 Financial Results On July 28
-
National Institute for Health and Care Excellence Provides Positive Guidance for Use of Boston Scientific GreenLight XPS™ Laser Therapy System in the Treatment of BPH
-
Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation
-
Boston Scientific To Participate In Goldman Sachs 2016 Healthcare Conference
-
Boston Scientific to Participate in Jefferies 2016 Healthcare Conference
-
Boston Scientific's (BSX) Precision Montage MRI SCS Approved by U.S. FDA
-
Boston Scientific Receives U.S. FDA Approval for Precision Montage™ MRI Spinal Cord Stimulator System
-
Boston Scientific Announces Schedule of Presentations at EuroPCR 2016
-
Boston Scientific Announces Positive Long-Term Outcomes For S-ICD System In The EFFORTLESS Study
-
Boston Scientific (BSX) Receives FDA Approval of Two Rhythmia-Related Catheters
-
Boston Scientific Announces U.S. FDA Approval of Navigation-Enabled Ablation Catheters
-
Boston Scientific To Participate In Bank Of America 2016 Healthcare Conference
-
Boston Scientific Announces Scheduled Presentations At Heart Rhythm Society 2016
-
Pre-Open Stock Movers 04/27: (SPA) (DWA) (WNC) Higher; (DVAX) (TWTR) (BWLD) Lower (more...)
-
Boston Scientific Announces Results For First Quarter 2016
-
Boston Scientific's (BSX) ImageReady MR-Conditional Pacing System Receives FDA Approval
-
Boston Scientific Receives U.S. FDA Approval For ImageReady™ MR-Conditional Pacing System
-
Boston Scientific To Participate In Deutsche Bank 2016 Healthcare Conference
-
Boston Scientific (BSX) EMBLEM S-ICD Systems Receive CE Mark
-
Boston Scientific Announces CE Mark For MRI Labeling Of Emblem™ S-ICD Systems
-
Boston Scientific To Webcast Conference Call Discussing First Quarter 2016 Financial Results On April 27
-
Boston Scientific To Participate In 15th Annual Needham Healthcare Conference
-
Boston Scientific Announces Scheduled Presentations at American College of Cardiology's 65th Annual Scientific Session
-
Boston Scientific (BSX) Announces Launch of AXIOS Stent and Electrocautery Enhanced Delivery System
-
Boston Scientific Launches the AXIOS™ Stent and Electrocautery Enhanced Delivery System
-
Boston Scientific (BSX) Enters Collaboration with Mayo Clinic to Speed Medcial Device Delopment
-
Boston Scientific, Mayo Clinic Collaborate to Speed Development of Medical Devices
-
FDA Approves Boston Scientific's (BSX) Blazer OI Catheter
-
Boston Scientific Receives U.S. FDA Approval For Blazer™ Open-Irrigated Catheter
-
Boston Scientific to Participate in Barclays Global Health Care Conference
-
Boston Scientific (BSX) Chairman Nicholas to Retire; Successor Named; Other Board Changes Announced
-
Boston Scientific Announces Changes to Board of Directors
-
Boston Scientific to Participate in Cowen & Company 2016 Health Care Conference
-
Boston Scientific's (BSX) ACUITY X4 Quadripolar LV Leads Approved by FDA
-
Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia
-
Boston Scientific (BSX) Announces Eluvia Drug-Eluting Stent Receives CE Mark
-
Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial
-
Boston Scientific Announces Medicare Will Cover WATCHMAN™ Left Atrial Appendage Closure Device
-
Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015
-
Boston Scientific (BSX), Accenture (ACN) Debut ADVANTICS Care Pathway Transformation Cloud Solution
-
Boston Scientific and Accenture Develop Data-Driven Digital Health Solution to Help Improve Patient Outcomes and Reduce Cost of Treating Chronic Cardiovascular Conditions
-
Boston Scientific to Participate in Leerink Partners 2016 Healthcare Conference
-
Boston Scientific Launches The LithoVue™ Single-Use Digital Flexible Ureteroscope In U.S. And Europe

